INTRATHECAL METHOTREXATE VERSUS CENTRAL NERVOUS-SYSTEM LEUKEMIA

被引：11

作者：

BLEYER, WA ^{[1
]}

机构：

[1] UNIV WASHINGTON,CHILDRENS ORTHOPED HOSP & MED CTR,SEATTLE,WA 98105

来源：

CANCER DRUG DELIVERY | 1984年 / 1卷 / 02期

关键词：

D O I：

10.1089/cdd.1984.1.157

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：157 / 167

页数：11

共 30 条

[1] AUR RJA, 1981, CANCER, V29, P331
[2] AZZARELLI B, 1977, ARCH PATHOL LAB MED, V101, P203
[3] BLEYER WA, 1978, CANCER-AM CANCER SOC, V41, P36, DOI 10.1002/1097-0142(197801)41:1<36::AID-CNCR2820410108>3.0.CO
[4] 2-I
[5] BLEYER WA, 1977, CANCER TREAT REP, V61, P703
[6] BLEYER WA, 1977, CANCER TREAT REP, V61, P1419
[7] REDUCTION IN CENTRAL NERVOUS-SYSTEM LEUKEMIA WITH A PHARMACOKINETICALLY DERIVED INTRATHECAL METHOTREXATE DOSAGE REGIMEN
BLEYER, WA
COCCIA, PF
SATHER, HN
LEVEL, C
LUKENS, J
NIEBRUGGE, DJ
SIEGEL, S
LITTMAN, PS
LEIKIN, SL
MILLER, DR
CHARD, RL
HAMMOND, GD
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1983, 1 (05) : 317 - 325
[8] BLEYER WA, 1982, LEUKEMIA, P865
[9] BLEYER WA, 1978, CLIN PHARM ANTINEOPL, P115
[10] BOWMAN WP, 1981, CANCER RES, V41, P4794